1 Min Read
May 5 (Reuters) - Genfit SA:
* First patient enrolled in a phase 2 trial recruiting adults with primary biliary cholangitis (PBC), a rare liver disease Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.